Arbormentis

Arbormentis, LLC is a private drug discovery company engaged in potentially transformative innovations for central nervous system disorders. The new licensing program stems from international collaboration among distinguished scientists from the United States, Europe, and Switzerland, focusing on the discovery and development of compounds that promote neuroplasticity.